Skip to main contentSkip to navigation
Sirius Investors

IMVT Earnings Reports, EPS & Revenue History

Quarterly EPS and revenue vs. estimates for Immunovant, Inc.. Review beat/miss history, upcoming consensus figures, and earnings call transcripts when available.

EPS and Earnings Announcement

Latest Quarterly EPS
Next Earnings Announcement
Unlock for free

Already registered? Sign in

EPS vs. Estimates

Green band = beat vs estimate · Red band = miss · Lines show actual and consensus EPS.

Revenue vs. Estimates

Green band = revenue beat · Red band = revenue miss · Lines show reported vs consensus revenue.

EPS & Revenue vs. Estimates

Upgrade
DateEPS ActualEPS Est.EPS Diff.Revenue ActualRevenue Est.Revenue Diff.
Aug 6, 2026Upcoming
May 20, 2026
-0.73-0.59-0.14
Feb 6, 2026
-0.61-0.72+0.116.00M
Nov 10, 2025
-0.73-0.72-0.01
Aug 11, 2025
May 29, 2025
Feb 6, 2025
Nov 7, 2024
Aug 6, 2024
May 29, 2024
Feb 12, 2024
Nov 9, 2023
Aug 10, 2023
May 22, 2023
Feb 3, 2023
Nov 4, 2022
Aug 5, 2022
Jun 8, 2022
Feb 4, 2022
Nov 5, 2021
Aug 9, 2021
Jun 1, 2021
Feb 16, 2021
Nov 12, 2020
Aug 12, 2020
Jun 29, 2020
Feb 14, 2020
Nov 6, 2019
Aug 12, 2019
Jun 12, 2019
Dec 31, 2018
Sep 30, 2018
Jun 30, 2018

Earnings Call Transcripts

Upgrade

Earnings Call Transcripts Require Subscription

Access to earnings call transcripts and AI-powered summaries is available for Pro, Premium, and Enterprise subscribers.

View Pricing Plans

Revenue Breakdown

Want to understand IMVT's revenue sources? Explore detailed revenue breakdowns by product line and geographic region to see what's driving the company's top line.

View Revenue Breakdown